The sentinel lymph node biopsy in breast cancer in the practice of the Brazilian gynecologist: A revision;A pesquisa do linfonodo sentinela para o câncer de mama na prática clínica do ginecologista brasileiro

Revista Brasileira de Ginecologia e Obstetricia

Volumn 29, Issue 3, 2007, Pages 158-164

  Quadros, Luis Gerk De Azevedo ^a   Gebrim, Luiz Henrique ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Estado de São Paulo ^*  (Brazil)

Author keywords

Breast neoplasms; False negative reactions; Lymph nodes surgery; Sentinel lymph node biopsy

Indexed keywords

EID: 34447134172     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Martin C, Cutuli B, Velten M. Predictive model of axillary lymph node involvement in women with small invasive breast carcinoma: axillary metastases in breast carcinoma. Cancer. 2002;94(2):314-22.
2. Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, et al. Prerandomization surgical training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg. 2005;241(1):48-54.
3. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546-53.
4. Maza S, Valencia R, Geworski L, Zander A, Guski H, Winzer KJ, et al. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study. Eur J Nucl Med Mol Imaging. 2003;30(5):651-6.
5. Barros ACSD, Barbosa EM, Gebrim LH, Anelli A, Figueira Filho A, Del Giglio A, et al. Diagnóstico e tratamento do câncer de mama. In: Projeto diretrizes. Brasília: Associação Médica Brasileira/Conselho Federal de Medicina; 2002. v. 2.
6. Posther KE, McCall LM, Blumencranz PW, Burak WE Jr, Beitsch PD, Hansen NM, et al. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg. 2005;242(4):593-602.
7. Goyal A, Newcombe RG, Chhabra A, Mansel RE; ALMANAC Trialists Group. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99(2):203-8.
8. Chagpar AB, Martin RC, Scoggins CR, Carlson DJ, Laidley AL, El-Eid SE, et al. Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery. 2005;138(1):56-63.
9. nd, Chagpar AB, Scoggins CR, Edwards MJ, Hagendoorn L, Stromberg AJ, et al. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg. 2005;241(6):1005-15.
10. nd, Carlson DJ, Laidley AL, et al. Surgeon and community factors affecting breast cancer sentinel lymph node biopsy. Am J Surg. 2005;190(6):915-9.
11. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. J Natl Cancer Inst. 2006;98(9):599-609.
12. Luini A, Galimberti V, Gatti G, Arnone P, Vento AR, Trifiro G, et al. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat. 2005;89(2):159-63.
13. Veronesi U, Galimberti V, Mariani L, Gatti G, Paganelli G, Viale G, et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer. 2005;41(2):231-7.
14. Zavagno G, Carcoforo P, Franchini Z, Renier M, Barutta L, De Salvo GL, et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol. 2005;31(7):715-20.
15. Smidt ML, Janssen CM, Kuster DM, Bruggink ED, Strobbe LJ. Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol. 2005;12(1):29-33.
16. Ung OA. Australasian experience and trials in sentinel lymph node biopsy: The RACS SNAC trial. Asian J Surg. 2004;27(4):284-90.
17. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95(3):279-93.
18. Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases. Breast Cancer Res Treat. 2006;98(3):311-4.
19. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow up of 4008 procedures. Ann Surg. 2004;240(3):462-8.
20. Intra M, Veronesi P, Mazzarol G, Galimberti V, Luini A, Sacchini V, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg. 2003;138(3):309-13.
21. Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol. 2004;15(9):1348-51.
22. Trocha SD, Giuliano AE. Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer. Surg Oncol. 2003;12(4):271-6.
23. Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol B-27. J Clin Oncol. 2005;23(12):2694-702.